↓ Skip to main content

Clotiapine for acute psychotic illnesses

Overview of attention for article published in Cochrane database of systematic reviews, October 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
6 tweeters
weibo
1 weibo user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
108 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clotiapine for acute psychotic illnesses
Published in
Cochrane database of systematic reviews, October 2004
DOI 10.1002/14651858.cd002304.pub2
Pubmed ID
Authors

Michael Berk, John Rathbone, Simone L Mandriota-Carpenter

Abstract

Acute psychotic illnesses, especially when associated with agitated or violent behaviour, require urgent pharmacological tranquillisation or sedation. Clotiapine, a dibenzothiazepine neuroleptic, is being used for this purpose in several countries.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 <1%
Unknown 107 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 19%
Researcher 16 15%
Student > Bachelor 14 13%
Student > Ph. D. Student 13 12%
Student > Postgraduate 7 6%
Other 20 19%
Unknown 18 17%
Readers by discipline Count As %
Medicine and Dentistry 33 31%
Psychology 20 19%
Nursing and Health Professions 12 11%
Social Sciences 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Other 11 10%
Unknown 20 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2017.
All research outputs
#3,063,420
of 15,934,748 outputs
Outputs from Cochrane database of systematic reviews
#5,812
of 11,329 outputs
Outputs of similar age
#33,238
of 168,852 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 113 outputs
Altmetric has tracked 15,934,748 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,329 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.6. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,852 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.